Although shortages in CT contrast agents may have generated more headlines in 2022, a recent radiologists survey conducted by Bracco found that nearly 25% of respondents have also experienced supply issues with the gadolinium-based contrast agents (GBCAs) used in MRI over the past few years.
During a roundtable discussion sponsored by Bracco and moderated by AuntMinnie.com at RSNA 2022, academic luminaries and Bracco executives shared the survey results and discussed steps that could be taken to solidify the supply of GBCAs for use in MRI, now and in the future. They also assessed topics such as patient safety, greater utilization of MRI contrast, and how to deal with a patient population that’s increasingly educated about these contrast agents.
“We need to think about redundancies in the supply chain,” said Fulvio Renoldi Bracco, vice-chairman & CEO of Bracco Imaging. "We need to design a system that is economically viable and, at the same time, guarantees security for our customers and, in particular, our patients.”
The group also reviewed topics such as patient safety, greater utilization of MRI contrast, and engaging with a patient population that’s increasingly educated about these contrast agents.
Looking ahead to the future of radiology, the panelists offered their perspectives on the potential role of artificial intelligence (AI) technology in helping to address the rising cost of healthcare spending. What’s more, they shared their views on how healthcare professionals, academia, governments, and industry can work together to foster innovation.
Click below for the video.
